BIDU [Baidu] 424B2: CALCULATION OF REGISTRATION FEE Title of Each Class

[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities To Be Registered Amount Proposed Offering Price Proposed Aggregate Amount of 2.250% Notes due 2017 US$750,000,000 99.929% US$749,467,500 US$102,227 3.500% Notes due 2022 US$750,000,000 99.849% US$748,867,500 US$102,146 (1) Prospectus Supplement (To Prospectus dated November 5, 2012) US$1,500,000,000 Baidu, Inc. US$750,000,000 2.250% Notes due 2017 US$750,000,000 3.500% Notes due 2022 We]

CBPO [China Biologic Products] 8-K: CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES

[CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES ____________________________________________________________ 1. He is the duly elected and acting Chief Executive Officer of China Biologic Products, Inc., a Delaware corporation (the “ Corporation ”). Board Preferred Stock ”), of the Corporation designated as Series A Participating Preferred Stock: RESOLVED Charter ”), the Board does hereby provide for the issuance of a series] [PREFERRED SHARES RIGHTS AGREEMENT Dated as of November 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION as Rights Agent TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 11 12 Section 6. Transfer, Split Up, Combination and Exchange] [CHINA BIOLOGIC PRODUCTS, INC. ADOPTS STOCKHOLDER RIGHTS PLAN The stockholder rights plan, which has a term of two years, is designed to guard against partial tender offers and other coercive tactics to gain control or undue influence of China Biologic without offering a fair and adequate price and terms to China Biologic’s stockholders. The plan does not prevent China Biologic’s] [FORM 8-K Current Report Date of Report (Date of earliest event reported): CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building 19 Chaoyang Park Road 86-10-6698-3166 (Former name or address, if changed since last report) Item 1.01. Entry into a Material Definitive Agreement. On November 19, 2012, the Board]

CCM [Concord Medical Services] 6-K: CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the “Company”) NOTICE

[CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the “Company”) NOTICE OF ANNUAL GENERAL MEETING NOTICE (i) “THAT the appointment of the Independent Auditor Ernst & Young Hua Ming for the fiscal year 2011 at a fee agreed by the directors be and is hereby ratified, confirmed, approved and adopted in all respects”. (ii) “THAT the appointment of the Independent Auditor Ernst &] [CONCORD MEDICAL SERVICES HOLDINGS LIMITED (the “Company”) SHAREHOLDER PROXY , Meeting Name of third preference I/We, This form is to be used in respect of the resolutions mentioned below as follows: IN FAVOUR OF AGAINST Resolution 1 ¨ ¨ “THAT the appointment of the Independent Auditor Ernst & Young Hua Ming for the fiscal year 2011 at a fee agreed] [TABLE OF CONTENTS EX-99.1 EX-99.2 TABLE OF CONTENTS CONCORD MEDICAL SERVICES HOLDINGS LIMITED]

BIDU [Baidu] 6-K: (Original Filing)

[Baidu Announces Pricing of US$1,500,000,000 Notes Offering The Company expects to receive net proceeds from the offering of approximately US$1,491.6 million, after deducting underwriting discounts and commissions and estimated net offering expenses. The Company intends to use a portion of the net proceeds from the offering to retire certain existing debt and the remainder for general corporate purposes. The joint] [BAIDU, INC. Robin Yanhong Li Chairman and Chief Executive Officer Description of Document]

Skip to toolbar